Annual CFO
-$699.70 K
-$290.20 K-70.87%
31 December 2023
Summary:
China Pharma Holdings annual cash flow from operations is currently -$699.70 thousand, with the most recent change of -$290.20 thousand (-70.87%) on 31 December 2023. During the last 3 years, it has fallen by -$657.40 thousand (-1554.14%). CPHI annual CFO is now -106.56% below its all-time high of $10.67 million, reached on 31 December 2009.CPHI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$47.00 K
+$25.70 K+35.35%
30 September 2024
Summary:
China Pharma Holdings quarterly cash flow from operations is currently -$47.00 thousand, with the most recent change of +$25.70 thousand (+35.35%) on 30 September 2024. Over the past year, it has dropped by -$1.05 million (-104.67%). CPHI quarterly CFO is now -100.96% below its all-time high of $4.91 million, reached on 30 September 2008.CPHI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$727.20 K
-$1.05 M-322.32%
30 September 2024
Summary:
China Pharma Holdings TTM cash flow from operations is currently -$727.20 thousand, with the most recent change of -$1.05 million (-322.32%) on 30 September 2024. Over the past year, it has dropped by -$634.50 thousand (-684.47%). CPHI TTM CFO is now -106.68% below its all-time high of $10.89 million, reached on 30 June 2010.CPHI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.9% | -104.7% | -684.5% |
| 3 y3 years | -1554.1% | +89.6% | -356.8% |
| 5 y5 years | -137.2% | -109.8% | -148.3% |
CPHI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1554.1% | at low | -104.7% | +96.8% | -322.3% | +61.0% |
| 5 y | 5 years | -137.2% | at low | -104.7% | +96.8% | -148.3% | +61.0% |
| alltime | all time | -106.6% | +59.7% | -101.0% | +98.0% | -106.7% | +80.2% |
China Pharma Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$47.00 K(-35.4%) | -$727.20 K(-322.3%) |
| June 2024 | - | -$72.70 K(-87.6%) | $327.10 K(+78.4%) |
| Mar 2024 | - | -$585.20 K(+2524.2%) | $183.40 K(-126.2%) |
| Dec 2023 | -$699.70 K(+70.9%) | -$22.30 K(-102.2%) | -$699.60 K(+654.7%) |
| Sept 2023 | - | $1.01 M(-565.5%) | -$92.70 K(-89.5%) |
| June 2023 | - | -$216.40 K(-85.3%) | -$880.90 K(-11.8%) |
| Mar 2023 | - | -$1.47 M(-351.1%) | -$998.30 K(+143.8%) |
| Dec 2022 | -$409.50 K(+63.9%) | $584.60 K(+166.8%) | -$409.50 K(-65.7%) |
| Sept 2022 | - | $219.10 K(-165.6%) | -$1.19 M(-36.0%) |
| June 2022 | - | -$333.80 K(-62.0%) | -$1.86 M(+118.5%) |
| Mar 2022 | - | -$879.40 K(+343.9%) | -$852.30 K(+241.2%) |
| Dec 2021 | -$249.80 K(+490.5%) | -$198.10 K(-56.1%) | -$249.80 K(-188.2%) |
| Sept 2021 | - | -$450.80 K(-166.7%) | $283.20 K(-44.4%) |
| June 2021 | - | $676.00 K(-344.1%) | $509.60 K(-779.5%) |
| Mar 2021 | - | -$276.90 K(-182.7%) | -$75.00 K(+77.3%) |
| Dec 2020 | -$42.30 K(-107.0%) | $334.90 K(-249.2%) | -$42.30 K(-89.4%) |
| Sept 2020 | - | -$224.40 K(-345.5%) | -$399.30 K(-230.8%) |
| June 2020 | - | $91.40 K(-137.4%) | $305.30 K(-49.2%) |
| Mar 2020 | - | -$244.20 K(+1005.0%) | $600.50 K(-1.3%) |
| Dec 2019 | $608.30 K(-67.7%) | -$22.10 K(-104.6%) | $608.20 K(-59.6%) |
| Sept 2019 | - | $480.20 K(+24.2%) | $1.50 M(-21.1%) |
| June 2019 | - | $386.60 K(-263.5%) | $1.91 M(+70.1%) |
| Mar 2019 | - | -$236.50 K(-127.0%) | $1.12 M(-40.4%) |
| Dec 2018 | $1.88 M(+123.7%) | $874.40 K(-1.0%) | $1.88 M(-3.2%) |
| Sept 2018 | - | $883.30 K(-321.2%) | $1.94 M(+11.8%) |
| June 2018 | - | -$399.30 K(-176.2%) | $1.74 M(+28.3%) |
| Mar 2018 | - | $523.70 K(-44.1%) | $1.36 M(+61.1%) |
| Dec 2017 | $841.20 K(-71.0%) | $936.80 K(+38.2%) | $841.30 K(-39.0%) |
| Sept 2017 | - | $678.00 K(-186.6%) | $1.38 M(-12.0%) |
| June 2017 | - | -$783.30 K(-8092.9%) | $1.57 M(-2.2%) |
| Mar 2017 | - | $9800.00(-99.3%) | $1.60 M(-44.7%) |
| Dec 2016 | $2.90 M(-13.6%) | $1.47 M(+70.1%) | $2.90 M(-29.7%) |
| Sept 2016 | - | $866.80 K(-215.8%) | $4.12 M(-6.8%) |
| June 2016 | - | -$748.30 K(-157.4%) | $4.42 M(-5.0%) |
| Mar 2016 | - | $1.30 M(-51.7%) | $4.66 M(+39.0%) |
| Dec 2015 | $3.35 M(-45.6%) | $2.70 M(+131.1%) | $3.35 M(-20.4%) |
| Sept 2015 | - | $1.17 M(-327.4%) | $4.21 M(+30.6%) |
| June 2015 | - | -$513.50 K(>+9900.0%) | $3.22 M(-11.9%) |
| Mar 2015 | - | -$2200.00(-100.1%) | $3.66 M(-40.5%) |
| Dec 2014 | $6.15 M(-28.4%) | $3.56 M(+1847.8%) | $6.15 M(-17.9%) |
| Sept 2014 | - | $182.60 K(-336.8%) | $7.49 M(-5.8%) |
| June 2014 | - | -$77.10 K(-103.1%) | $7.95 M(-20.3%) |
| Mar 2014 | - | $2.49 M(-49.1%) | $9.98 M(+16.1%) |
| Dec 2013 | $8.60 M(+135.9%) | $4.90 M(+665.3%) | $8.60 M(+96.6%) |
| Sept 2013 | - | $640.00 K(-67.2%) | $4.37 M(-9.1%) |
| June 2013 | - | $1.95 M(+76.1%) | $4.81 M(+10.5%) |
| Mar 2013 | - | $1.11 M(+64.4%) | $4.35 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $3.64 M(-30.4%) | $673.90 K(-37.3%) | $3.64 M(+30.3%) |
| Sept 2012 | - | $1.08 M(-28.0%) | $2.80 M(-20.6%) |
| June 2012 | - | $1.49 M(+271.9%) | $3.52 M(-17.1%) |
| Mar 2012 | - | $401.40 K(-332.2%) | $4.25 M(-18.8%) |
| Dec 2011 | $5.24 M(-32.7%) | -$172.90 K(-109.6%) | $5.24 M(-26.6%) |
| Sept 2011 | - | $1.80 M(-18.8%) | $7.14 M(-12.0%) |
| June 2011 | - | $2.22 M(+60.2%) | $8.11 M(+0.8%) |
| Mar 2011 | - | $1.39 M(-19.6%) | $8.05 M(+3.4%) |
| Dec 2010 | $7.79 M(-27.0%) | $1.73 M(-37.9%) | $7.79 M(-24.7%) |
| Sept 2010 | - | $2.78 M(+28.8%) | $10.34 M(-5.0%) |
| June 2010 | - | $2.16 M(+92.1%) | $10.89 M(+2.0%) |
| Mar 2010 | - | $1.12 M(-73.8%) | $10.68 M(+0.1%) |
| Dec 2009 | $10.67 M(+63.1%) | $4.28 M(+28.7%) | $10.67 M(+19.8%) |
| Sept 2009 | - | $3.33 M(+71.0%) | $8.90 M(-15.1%) |
| June 2009 | - | $1.94 M(+74.1%) | $10.49 M(+70.9%) |
| Mar 2009 | - | $1.12 M(-55.6%) | $6.14 M(-6.2%) |
| Dec 2008 | $6.54 M(+133.5%) | $2.52 M(-48.8%) | $6.54 M(-14.4%) |
| Sept 2008 | - | $4.91 M(-304.1%) | $7.65 M(+95.1%) |
| June 2008 | - | -$2.41 M(-258.2%) | $3.92 M(-31.6%) |
| Mar 2008 | - | $1.52 M(-58.0%) | $5.73 M(+104.5%) |
| Dec 2007 | $2.80 M(-261.4%) | $3.62 M(+205.2%) | $2.80 M(-948.8%) |
| Sept 2007 | - | $1.19 M(-298.3%) | -$330.10 K(-91.0%) |
| June 2007 | - | -$597.90 K(-57.5%) | -$3.67 M(+36.4%) |
| Mar 2007 | - | -$1.41 M(-388.4%) | -$2.69 M(+54.9%) |
| Dec 2006 | -$1.74 M(+286.6%) | $487.30 K(-122.6%) | -$1.74 M(-21.9%) |
| Sept 2006 | - | -$2.15 M(-665.0%) | -$2.22 M(+2595.4%) |
| June 2006 | - | $381.00 K(-184.3%) | -$82.50 K(-87.6%) |
| Mar 2006 | - | -$451.90 K(+3795.7%) | -$663.60 K(+213.5%) |
| Dec 2005 | -$449.10 K(+124.4%) | - | - |
| Sept 2005 | - | -$11.60 K(-94.2%) | -$211.70 K(+5.8%) |
| June 2005 | - | -$200.10 K(<-9900.0%) | -$200.10 K(<-9900.0%) |
| June 2005 | -$200.10 K(+458.9%) | - | - |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2004 | - | $0.00(0.0%) | -$300.00(-99.2%) |
| June 2004 | -$35.80 K(-61.5%) | $0.00(0.0%) | -$35.80 K(+59.1%) |
| Mar 2004 | - | $0.00(-100.0%) | -$22.50 K(-79.5%) |
| Dec 2003 | - | -$300.00(-99.2%) | -$109.90 K(-34.9%) |
| Sept 2003 | - | -$35.50 K(-366.9%) | -$168.90 K(+81.4%) |
| June 2003 | -$93.10 K(-68.9%) | $13.30 K(-115.2%) | -$93.10 K(-65.1%) |
| Mar 2003 | - | -$87.40 K(+47.4%) | -$266.60 K(+55.2%) |
| Dec 2002 | - | -$59.30 K(-247.1%) | -$171.80 K(+6.7%) |
| Sept 2002 | - | $40.30 K(-125.2%) | -$161.00 K(-46.2%) |
| June 2002 | -$299.20 K | -$160.20 K(-2264.9%) | -$299.10 K(+115.3%) |
| Mar 2002 | - | $7400.00(-115.3%) | -$138.90 K(-5.1%) |
| Dec 2001 | - | -$48.50 K(-50.4%) | -$146.30 K(+49.6%) |
| Sept 2001 | - | -$97.80 K | -$97.80 K |
FAQ
- What is China Pharma Holdings annual cash flow from operations?
- What is the all time high annual CFO for China Pharma Holdings?
- What is China Pharma Holdings annual CFO year-on-year change?
- What is China Pharma Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for China Pharma Holdings?
- What is China Pharma Holdings quarterly CFO year-on-year change?
- What is China Pharma Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for China Pharma Holdings?
- What is China Pharma Holdings TTM CFO year-on-year change?
What is China Pharma Holdings annual cash flow from operations?
The current annual CFO of CPHI is -$699.70 K
What is the all time high annual CFO for China Pharma Holdings?
China Pharma Holdings all-time high annual cash flow from operations is $10.67 M
What is China Pharma Holdings annual CFO year-on-year change?
Over the past year, CPHI annual cash flow from operations has changed by -$290.20 K (-70.87%)
What is China Pharma Holdings quarterly cash flow from operations?
The current quarterly CFO of CPHI is -$47.00 K
What is the all time high quarterly CFO for China Pharma Holdings?
China Pharma Holdings all-time high quarterly cash flow from operations is $4.91 M
What is China Pharma Holdings quarterly CFO year-on-year change?
Over the past year, CPHI quarterly cash flow from operations has changed by -$1.05 M (-104.67%)
What is China Pharma Holdings TTM cash flow from operations?
The current TTM CFO of CPHI is -$727.20 K
What is the all time high TTM CFO for China Pharma Holdings?
China Pharma Holdings all-time high TTM cash flow from operations is $10.89 M
What is China Pharma Holdings TTM CFO year-on-year change?
Over the past year, CPHI TTM cash flow from operations has changed by -$634.50 K (-684.47%)